Optellum
Optellum develops an imaging biomarker for smart lung cancer detection.
Optellum has raised €16M across 2 funding rounds from 7 investors, most recently a Series A round in Sep 2022. Based in Oxford, UK; founded 2016; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€16M
€15,632,185
Funding rounds
2
Investors
7
distinct backers
Active since
2019-07
latest 2022-09
Funding by year
EUR raised per yearOptellum — funding by year — interactive chart.
Data table
| Optellum — funding by year | |
|---|---|
| 2019 | €1.1M |
| 2022 | €15M |
Signals
High confidenceRaise-next likelihood9
base rate 44% for Series A
- ▼ Past typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood9
base rate 11% (2+ rounds)
- ▲ 10y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-09-27 | Series A | €15M | Black Opal Ventures,family office of Sir Martin & Lady Audrey Wood,Intuitive Ventures,IQ Capital,Mercia Ventures,St John’s College | View deal → |
| 2019-07-01 | Seed | €1.1M | Luminous Ventures | View deal → |